EMA — authorised 29 June 2016
- Marketing authorisation holder: AOP Orphan Pharmaceuticals AG
- Status: approved
🇪🇺 Onoact in European Union
EMA authorised Onoact on 29 June 2016
Marketing authorisation
Onoact in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Onoact approved in European Union?
Yes. EMA authorised it on 29 June 2016.
Who is the marketing authorisation holder for Onoact in European Union?
AOP Orphan Pharmaceuticals AG holds the EU marketing authorisation.